美股A股
StockGist
Back
8-K2026-03-12· grok-4-1-fast-non-reasoning

ALLO · Allogene Therapeutics, Inc.

0001628280-26-017230

SEC filing

Summary

Allogene Therapeutics, Inc. furnished Item 2.02 results of operations and Exhibit 99.1 press release dated March 12, 2026, pursuant to SEC Form 8-K filed on March 12, 2026. The disclosure is not deemed 'filed' under Section 18 of the Securities Exchange Act of 1934.

Key takeaways